Dimethyl fumarate

Randomised Evaluation of COVID-19 Therapy

A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)

A Study to Evaluate Long-Term Safety of Vumerity and Tecfidera in Participants With Multiple Sclerosis (MS)

Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)

Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)

A Study of Dimethyl Fumarate (DMF) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in China

Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease

Dimethyl Fumarate in Adrenomyeloneuropathy

IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS Study

Dimethyl Fumarate for the Treatment of Intracerebral Hemorrhage

Combination of the Immune Modulator Dimethyl Fumarate With Intraarterial Treatment in Acute Ischemic Stroke

Impact of an Immune Modulator Dimethyl Fumarate on Acute Ischemic Stroke

Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by Tecfidera

Dimethyl Fumarate (DMF, Tecfidera®) Persistence in RR-MS Patients Included in the French Patient Support Program OroSEP

Dimethyl Fumarate Treatment for Intracranial Unruptured Aneurysms.

Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric Participants

Dimethyl Fumarate (DMF) Observational Study

Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL)

Relationship Between Oral DMT Burden and Adherence in MS

Biogen Multiple Sclerosis Pregnancy Exposure Registry